191 related articles for article (PubMed ID: 34172077)
1. Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Hopkin RJ
Orphanet J Rare Dis; 2021 Jun; 16(1):285. PubMed ID: 34172077
[TBL] [Abstract][Full Text] [Related]
2. Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Iaconangelo C; Serrano D; Modur V; Politei J
Mol Genet Metab Rep; 2021 Dec; 29():100824. PubMed ID: 34900595
[TBL] [Abstract][Full Text] [Related]
3. Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study.
Wanner C; Kimonis V; Politei J; Warnock DG; Üçeyler N; Frey A; Cornelisse P; Hughes D
Mol Genet Metab Rep; 2022 Jun; 31():100862. PubMed ID: 35782623
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents.
Berry L; Walter J; Johnson J; Alton J; Powers J; Llòria X; Koulinska I; McGee M; Laney D
Orphanet J Rare Dis; 2024 Apr; 19(1):153. PubMed ID: 38605390
[TBL] [Abstract][Full Text] [Related]
5. Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ).
Ramaswami U; Stull DE; Parini R; Pintos-Morell G; Whybra C; Kalkum G; Rohrbach M; Raluy-Callado M; Beck M; Chen WH; Wiklund I;
Health Qual Life Outcomes; 2012 Sep; 10():116. PubMed ID: 22992222
[TBL] [Abstract][Full Text] [Related]
6. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
[TBL] [Abstract][Full Text] [Related]
7. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
[TBL] [Abstract][Full Text] [Related]
8. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
[TBL] [Abstract][Full Text] [Related]
9. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.
Raymond K; Maher S; Saucier CD; O'Connor M; Yarlas A; Kosinski M; Chen WH; Gairy K
Rheumatol Ther; 2023 Feb; 10(1):95-115. PubMed ID: 36227531
[TBL] [Abstract][Full Text] [Related]
10. Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire.
Noël E; Dussol B; Lacombe D; Bedreddine N; Fouilhoux A; Ronco P; Genevaz D; Bekri S; Hagège A; Dupuis-Siméon F; Derrien Ansquer V; Germain DP; Lidove O
Orphanet J Rare Dis; 2019 Dec; 14(1):284. PubMed ID: 31801581
[TBL] [Abstract][Full Text] [Related]
11. "Lower abdominal pains, as if I was being squeezed…in a clamp": A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer.
Martin ML; Halling K; Eek D; Reaney M
Patient; 2020 Apr; 13(2):189-200. PubMed ID: 31691205
[TBL] [Abstract][Full Text] [Related]
12. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
[TBL] [Abstract][Full Text] [Related]
13. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
[TBL] [Abstract][Full Text] [Related]
14. Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.
Gounder MM; Maddux L; Paty J; Atkinson TM
Cancer; 2020 Feb; 126(3):531-539. PubMed ID: 31691276
[TBL] [Abstract][Full Text] [Related]
15. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
[TBL] [Abstract][Full Text] [Related]
16. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
[TBL] [Abstract][Full Text] [Related]
19. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of symptoms in female Fabry disease patients: a case-control survey.
Bouwman MG; Rombach SM; Schenk E; Sweeb A; Wijburg FA; Hollak CE; Linthorst GE
J Inherit Metab Dis; 2012 Sep; 35(5):891-8. PubMed ID: 22431073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
